يعرض 261 - 280 نتائج من 21,342 نتيجة بحث عن '(( significant decrease decrease ) OR ( significant largest decrease ))*', وقت الاستعلام: 0.40s تنقيح النتائج
  1. 261
  2. 262

    Cohesion correction coefficient. حسب Zhezhe Zhang (19704587)

    منشور في 2024
    الموضوعات:
  3. 263

    Fig 18 in each curve fitting results. حسب Zhezhe Zhang (19704587)

    منشور في 2024
    الموضوعات:
  4. 264

    Fig 29 in each curve fitting results. حسب Zhezhe Zhang (19704587)

    منشور في 2024
    الموضوعات:
  5. 265
  6. 266

    Specimen packaging process. حسب Zhezhe Zhang (19704587)

    منشور في 2024
    الموضوعات:
  7. 267
  8. 268
  9. 269
  10. 270

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> حسب Razia Rashid Rahil (22772495)

    منشور في 2025
    "…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …"
  11. 271
  12. 272
  13. 273

    Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
  14. 274

    Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
  15. 275
  16. 276
  17. 277
  18. 278
  19. 279
  20. 280

    Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. حسب Francesca Catto (21253435)

    منشور في 2025
    "…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …"